The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 18, 2020
Filed:
Oct. 19, 2017
Applicant:
Sunovion Pharmaceuticals Inc., Marlborough, MA (US);
Inventors:
John Emmerson Campbell, Cambridge, MA (US);
Michael Charles Hewitt, Somerville, MA (US);
Philip Xinhe Jones, Danvers, MA (US);
Linghong Xie, Southborough, MA (US);
Assignee:
Sunovion Pharmaceuticals, Inc., Marlborough, MA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/498 (2006.01); C07D 241/40 (2006.01); C07D 498/06 (2006.01); C07D 401/06 (2006.01); C07D 471/04 (2006.01); C07D 471/14 (2006.01); C07D 487/04 (2006.01); C07D 491/056 (2006.01); C07D 498/14 (2006.01); C07D 519/00 (2006.01); C07D 403/06 (2006.01); C07D 401/14 (2006.01); C07D 405/14 (2006.01); C07D 409/06 (2006.01); C07D 409/14 (2006.01); C07D 413/06 (2006.01); C07D 417/06 (2006.01); C07D 498/04 (2006.01); A61K 31/4164 (2006.01); A61K 31/4178 (2006.01); A61K 31/4709 (2006.01); A61K 31/4985 (2006.01); A61K 31/506 (2006.01); A61K 31/517 (2006.01); A61K 31/5383 (2006.01); C07D 233/58 (2006.01); C07D 471/06 (2006.01);
U.S. Cl.
CPC ...
C07D 498/06 (2013.01); A61K 31/4164 (2013.01); A61K 31/4178 (2013.01); A61K 31/4709 (2013.01); A61K 31/498 (2013.01); A61K 31/4985 (2013.01); A61K 31/506 (2013.01); A61K 31/517 (2013.01); A61K 31/5383 (2013.01); C07D 233/58 (2013.01); C07D 401/06 (2013.01); C07D 401/14 (2013.01); C07D 403/06 (2013.01); C07D 405/14 (2013.01); C07D 409/06 (2013.01); C07D 409/14 (2013.01); C07D 413/06 (2013.01); C07D 417/06 (2013.01); C07D 471/04 (2013.01); C07D 471/06 (2013.01); C07D 471/14 (2013.01); C07D 487/04 (2013.01); C07D 491/056 (2013.01); C07D 498/04 (2013.01); C07D 498/14 (2013.01); C07D 519/00 (2013.01);
Abstract
Provided herein are cyclic nucleotide phosphodiesterase inhibitors, and pharmaceutical compositions thereof, useful for the treatment of, for example, central nervous system and metabolic diseases and disorder.